
RSV Vaccination in Older Adults: What New Evidence Means for Care
Respiratory syncytial virus causes serious illness and hospitalization in older adults. New randomized data now show that RSV vaccination significantly reduces RSV related hospitalizations and severe respiratory outcomes. This article explains how RSV vaccines work, who benefits most, and how new evidence may change current clinical practice for adults aged 60 and older.
Published
Categorized as Dr. Tashko’s Key Clinical Trials, Hospital, Insights from Dr. Tashko, Mortality, Vaccine
Jardiance for General Kidney Disease
A major Jardiance study for kidney disease. The results of a major clinical trial were recently published in the New England Journal of Medicine. The study was conducted to evaluate the efficacy of Empagliflozin (Jardiance) in patients with broad-range of chronic kidney disease (CKD) – irrespective of diabetes diagnosis. About 7,000 patients were randomly assigned to receive Jardiance 10 mg daily or placebo. The primary outcome was a combination of progression of CKD or mortality…
Published
Categorized as Blog, Diabetes Care, Heart Health, Hospital, Insights from Dr. Tashko, Kidney Health, Mortality
